Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

362 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 362 results

Large-scale testing (Phase 3)Study completedNCT01235598
What this trial is testing

Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 41
Early research (Phase 1)UnknownNCT00002449
What this trial is testing

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Who this might be right for
HIV Infections
Chiron Corporation 212
Large-scale testing (Phase 3)Study completedNCT00767325
What this trial is testing

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 104
Not applicableEnded earlyNCT01196780
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,240
Testing effectiveness (Phase 2)Study completedNCT05198310
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Who this might be right for
Arthritis, Rheumatoid
Kiniksa Pharmaceuticals, Ltd. 145
Large-scale testing (Phase 3)Study completedNCT03086343
What this trial is testing

Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 657
Testing effectiveness (Phase 2)Study completedNCT01511250
What this trial is testing

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Who this might be right for
Healthy
Takeda 360
Large-scale testing (Phase 3)Study completedNCT01254331
What this trial is testing

An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 51
Large-scale testing (Phase 3)Study completedNCT01057771
What this trial is testing

Meditation and Exercise for Prevention of Acute Respiratory Infection

Who this might be right for
Acute Respiratory Infection
University of Wisconsin, Madison 154
Testing effectiveness (Phase 2)Study completedNCT00799513
What this trial is testing

Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
IRCCS San Raffaele 48
Not applicableUnknownNCT04208074
What this trial is testing

Exercise Study for Breast Cancer Survivors

Who this might be right for
Breast Cancer
San Diego Biomedical Research Institute 30
Not applicableLooking for participantsNCT06880653
What this trial is testing

Dose Response of Exercise for Arthritis Management

Who this might be right for
ArthritisRheumatoid Arthritis (RA)Gout+3 more
University of South Carolina 285
Large-scale testing (Phase 3)Study completedNCT00160602
What this trial is testing

Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 590
Very early researchUnknownNCT04726553
What this trial is testing

Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Oklahoma Medical Research Foundation 20
Not applicableUnknownNCT04799808
What this trial is testing

Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff

Who this might be right for
SARS-CoV-2 InfectionActive ImmunizationImmune Response+1 more
Technische Universität Dresden 3,500
Post-approval studies (Phase 4)Study completedNCT01054053
What this trial is testing

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Have to be Vaccinated MenBVac®

Who this might be right for
Vaccination
University Hospital, Rouen 218
Testing effectiveness (Phase 2)Study completedNCT02472795
What this trial is testing

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Viatris Innovation GmbH 105
Post-approval studies (Phase 4)Study completedNCT00504777
What this trial is testing

MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 36
Testing effectiveness (Phase 2)Ended earlyNCT03681951
What this trial is testing

First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Who this might be right for
Neoplasms, Pancreatic
GlaxoSmithKline 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06993480
What this trial is testing

Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 20
Next Page